TED-R13-002
-
StatusAccepting Candidates
-
AgeAdults
-
SexesAll
-
Healthy VolunteersDoes Not Accept Healthy Volunteers
Objective
This is a global prospective, observational, multi-center registry to evaluate the long-term safety profile for participants with short bowel syndrome (SBS) who are treated with teduglutide in a routine clinical setting. The registry will also evaluate the long-term clinical outcomes in participants with SBS. SBS participants treated and not treated with teduglutide will be enrolled.
Details
| Full study title | A Prospective, Multi-center Registry for Patients with Short Bowel Syndrome |
| Protocol number | OCR19917 |
| ClinicalTrials.gov ID | NCT01990040 |
Eligibility
Inclusion Criteria:
- Male and female participants, of any age, with a diagnosis of short bowel syndrome (SBS).
- Signed informed consent and medical records release by the participant or a legally acceptable representative
- Participants who have never received teduglutide treatment must be on parenteral nutrition (PN)/intravenous (IV) fluids support for at least 6 months at the time of enrollment.
Exclusion criteria:
- Participants currently participating in a blinded clinical trial or their extension studies.
- Participants who have never been on PN/IV support.
- Participants who are currently or previously exposed to any Glucagon-like peptide 2 (GLP-2. analogs other than teduglutide.
Lead researcher
-
Angela Pham, MDGastroenterologist
Participate in a study
Here are some general steps to consider when participating in a research study:
-
Step1
Contact the research team
Call or email the research team listed within the specific clinical trial or study to let them know that you're interested. A member of the research team, such as the researcher or study coordinator, will be available to tell you more about the study and to answer any questions or concerns you may have.
Primary contact
-
Step2
Get screened to confirm eligibility
You may be asked to take part in prescreening to make sure you are eligible for a study. The prescreening process ensures it is safe for you to participate. During the prescreening process, you will be asked some questions and you may also be asked to schedule tests or procedures to confirm your eligibility.
-
Step3
Provide your consent to participate
If you are eligible and want to join the clinical trial or study, a member of the research team will ask for your consent to participate. To give consent, you will be asked to read and sign a consent form for the study. This consent form explains the study's purpose, procedures, risks, benefits and provides other important information, such as the study team's contact information.
-
Step4
Participate
If you decide to participate in a clinical trial or study, the research team will keep you informed of the study requirements and what you will need to do to throughout the study. For some trials or studies, your health care provider may work with the research team to ensure there are no conflicts with other medications or treatments.